Faruqi & Faruqi Reminds Hims & Hers Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 25, 2025 – HIMS

NEW YORK CITY, NY / ACCESS Newswire / July 31, 2025 / Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Hims To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Hims between April 29, 2025 and June 22, 2025 and would […]

Johnson Fistel Commences Investigation of Align Technology, Inc.

(NASDAQ:ALGN), SAN DIEGO, July 31, 2025 (GLOBE NEWSWIRE) — Johnson Fistel, PLLP, a shareholder rights law firm, announces that it is investigating potential claims on behalf of investors of Align Technology, Inc. (NASDAQ: ALGN) regarding possible violations of federal securities laws. What if I purchased Align Technology securities? If you incurred significant losses and want

Johnson Fistel Commences Investigation of Align Technology, Inc.

Johnson Fistel Commences Investigation of Align Technology, Inc. GlobeNewswire July 31, 2025 SAN DIEGO, July 31, 2025 (GLOBE NEWSWIRE) — Johnson Fistel, PLLP, a shareholder rights law firm, announces that it is investigating potential claims on behalf of investors of Align Technology, Inc. (NASDAQ: ALGN) regarding possible violations of federal securities laws. What if I

Statement from Class Counsel Jeffrey Kessler and Steve Berman Regarding Revised CSC Guidance for NIL Collectives

Today, the College Sports Commission (CSC) issued revised guidance on establishing a valid business purpose for names, images, and likenesses (NIL) payments to conform with the terms of theclass action settlement on behalf of college athletes with the NCAA, Big Ten, SEC, Pac-12, Big 12 and ACC. This new guidance corresponds to a joint statement

Faruqi & Faruqi Reminds iRobot Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 5, 2025 – IRBT

NEW YORK CITY, NY / ACCESS Newswire / July 31, 2025 / Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in iRobot To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in iRobot between January 29, 2024 and March 11, 2025 and would

Faruqi & Faruqi Reminds RxSight Investors of The Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 22, 2025 – RXST

NEW YORK CITY, NY / ACCESS Newswire / July 31, 2025 / Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In RxSight To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in RxSight between November 7, 2024 and July 8, 2025 and would

Clearwater Launches New Enterprise Cyber Risk Management Solution to Help Healthcare Organizations Reduce Cyber Risk, Strengthen Compliance, and Drive Boardroom Confidence

Clearwater, the largest pure-play provider of cybersecurity and compliance solutions for the healthcare industry, today announced the launch of its new Enterprise Cyber Risk Management (ECRM) solution. Designed to help healthcare organizations see and manage cyber risk with greater clarity, ECRM integrates Clearwater's industry-leading OCR-Quality® Risk Analysis with a comprehensive NIST Cybersecurity Framework (CSF) 2.0

Did You Lose Money on Biohaven Ltd. (BHVN)? Levi & Korsinsky Urges Investors to Act Before September 12, 2025

NEW YORK, NY / ACCESS Newswire / July 31, 2025 / If you suffered a loss on your Biohaven Ltd. (NYSE:BHVN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/biohaven-ltd-lawsuit-submission-form?prid=159100&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Investor Alert: Deadline Approaching to Join Rocket Pharmaceuticals, Inc. (RCKT) Class Action – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / July 31, 2025 / If you suffered a loss on your Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rocket-pharmaceuticals-inc-lawsuit-submission-form?prid=159099&wire=1&utm_campaign=25 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NV5 Stockholders Approve Proposed Merger with Acuren Corporation

(NASDAQ:NVEE), HOLLYWOOD, Fla., July 31, 2025 (GLOBE NEWSWIRE) — NV5 Global, Inc. (Nasdaq: NVEE) (“NV5” or the “Company”), a leading provider of tech-enabled engineering, testing, inspection, and consulting solutions for the built environment, announced today that holders of a majority of its outstanding common stock voted to approve the proposed merger (the “Merger”) with Acuren

Scroll to Top